Seven decades of antipsychotic drugs: Why is the life of Australians with schizophrenia still so suboptimal?
Aust N Z J Psychiatry
; 58(3): 201-206, 2024 Mar.
Article
en En
| MEDLINE
| ID: mdl-38130026
ABSTRACT
The advent of dopamine (D2) receptor-blocking medications over 70 years ago, ushered in a new era of biological treatment for schizophrenia. However, we argue that little subsequent progress has been made in translating this into fulfilled and fulfilling lives for people with schizophrenia. This Viewpoint asks why this is the case, and suggests ways forward for capitalising on extant and emerging new treatments for psychotic disorders, to the betterment of the lives of people living with schizophrenia.
Palabras clave
Texto completo:
1
Colección:
01-internacional
Banco de datos:
MEDLINE
Asunto principal:
Trastornos Psicóticos
/
Esquizofrenia
/
Antipsicóticos
/
Pueblos de Australasia
Límite:
Humans
País/Región como asunto:
Oceania
Idioma:
En
Revista:
Aust N Z J Psychiatry
Año:
2024
Tipo del documento:
Article
País de afiliación:
Australia